SMTL ID : 3l13.1

Crystal Structures of Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x JZW: [3-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenyl]methanol(Non-covalent)

JZW.1: 18 residues within 4Å: Chain A: K.660, M.662, A.663, I.689, D.694, L.696, D.699, Y.725, I.737, E.738, I.739, V.740, T.745, M.811, F.819, I.821, D.822, F.823 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.696, A:I.737, A:I.821, A:D.822 Hydrogen bonds: A:A.663, A:D.699, A:Y.725, A:V.740, A:D.822

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sutherlin, D.P. et al., Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer. J.Med.Chem. (2010)

Release Date

2010-02-16

Peptides

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence